Copyright
©The Author(s) 2024.
World J Diabetes. Apr 15, 2024; 15(4): 629-637
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.629
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.629
Group 1 (n = 41) | Group 2 (n = 31) | P value | ||
Age (years), mean ± SD | 0.66 | |||
66.0 (9.9) | 61.4 (10.9) | |||
Median (Q1 to Q3) | 65.0 (59.0 to 74.0) | 61 (56.0 to 66.5) | ||
Sex | 0.93 | |||
Female | 13 (31.7) | 11 (35.5) | ||
Male | 28 (68.3) | 20 (64.5) | ||
BMI, mean ± SD | 0.64 | |||
22.4 (3.8) | 22.8 (3.8) | |||
Median (Q1 to Q3) | 22.5 (19.5 to 24.4) | 22.2 (19.5 to 25.7) | ||
Location | 0.92 | |||
Right | 16 (39.0) | 14 (45.2) | ||
Left | 23 (56.1) | 16 (51.6) | ||
Both | 2 (4.9) | 1 (3.2) | ||
Dialysis | 0.86 | |||
No | 31 (75.6) | 22 (71.0) | ||
Yes | 10 (24.4) | 9 (29.0) | ||
Kidney transplant history | 0.02 | |||
No | 40 (97.6) | 21 (67.7) | ||
Yes | 1 (2.4) | 10 (32.3) | ||
Smoking | 0.71 | |||
No | 29 (70.7) | 24 (77.4) | ||
Yes | 12 (29.3) | 7 (22.6) | ||
Amputation history | 0.84 | |||
No | 22 (53.7) | 15 (48.4) | ||
Yes | 19 (46.3) | 16 (51.6) | ||
HTN | 0.06 | |||
No | 17 (41.5) | 4 (12.9) | ||
Yes | 24 (58.5) | 27 (87.1) | ||
Endovascular intervention history | 0.38 | |||
No | 29 (70.7) | 18 (58.1) | ||
Yes | 12 (29.3) | 13 (41.9) | ||
HbA1 | 7.54 | 9.32 | 0.01 | |
HbA1c ≥ 7.2 | 0.01 | |||
No | 18 (43.9) | 4 (12.9) | ||
Yes | 23 (56.1) | 27 (87.1) |
Univariable | Multivariable_all | ||||
OR (95%CI) | P value | OR (95%CI) | P value | ||
Age (years) | 0.96 (0.91-1.00) | 0.066 | 1.01 (0.93-1.09) | 0.866 | |
Sex | |||||
Female | - | - | |||
Male | 0.84 (0.31-2.29) | 0.737 | 0.53 (0.08-2.92) | 0.476 | |
BMI | 1.03 (0.91-1.17) | 0.630 | 1.10 (0.87-1.45) | 0.439 | |
Location | |||||
Right | - | - | |||
Left | 0.80 (0.30-2.08) | 0.640 | 0.62 (0.14-2.65) | 0.525 | |
Both | 0.57 (0.02-6.60) | 0.662 | 0.11 (0.00-3.08) | 0.239 | |
Kidney transplant history | |||||
No | - | - | |||
Yes | 19.05 (3.32-361.72) | 0.006a | 26.22 (2.36-811.46) | 0.020 | |
Smoking | |||||
No | - | - | |||
Yes | 0.70 (0.23-2.04) | 0.525 | 0.26 (0.04-1.52) | 0.150 | |
ICU | |||||
No | - | - | |||
Yes | 0.64 (0.23-1.71) | 0.379 | 0.20 (0.03-1.09) | 0.085 | |
HTN | |||||
No | - | - | |||
Yes | 4.78 (1.52-18.42) | 0.012 | 6.19 (1.20-44.22) | 0.054 | |
Endovascular intervention history | |||||
No | - | - | |||
Yes | 1.75 (0.66-4.72) | 0.266 | 2.86 (0.63-16.12) | 0.193 | |
HbA1c ≥ 7.2 | |||||
No | - | - | |||
Yes | 5.28 (1.69-20.33) | 0.007a | 31.28 (5.04-355.9) | 0.001 |
- Citation: Park YU, Eim SH, Seo YW. Prevalence and risk factors of wound complications after transtibial amputation in patients with diabetic foot. World J Diabetes 2024; 15(4): 629-637
- URL: https://www.wjgnet.com/1948-9358/full/v15/i4/629.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i4.629